Controversies in Prediabetes: Do We Have a Diagnosis?

References

• . Centers for Disease Control and Prevention; Department of Health and Human Services. National Diabetes Fact Sheet, 2011. http://www.cdc.gov/diabetes/pubs/pdf/ndfs_2011.pdf. Accessed April 16, 2012
   Google Scholar
• . Nguyen NT, Nguyen XM, Lane J, Wang P. Relationship between obesity and diabetes in a US adult population: findings from the National Health and Nutrition Examination Survey, 1999–2006. Obes Surg. 2011;21(3):351–355
   PubMedGoogle Scholar
• . Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2003;26( suppl 1):S5–S20
   PubMed Web of Science ®Google Scholar
• . Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 1997;20(7):1183–1197
   PubMed Web of Science ®Google Scholar
• . Alberti G, Zimmet P, Ryden L. Setting the scene: glucose intolerance—what's in a name? Presented at: 1st International Congress on “Prediabetes” and the Metabolic Syndrome; April 13–16, 2005; Berlin, Germany
   Google Scholar
• . Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care. 2010;33(11):2355–2359
   PubMed Web of Science ®Google Scholar
• . Buysschaert M, Bergman M. Definition of prediabetes. Med Clin North Am. 2011;95(2):289–297, vii
   PubMed Web of Science ®Google Scholar
• . Cowie CC, Rust KF, Ford ES, . Full accounting of diabetes and pre-diabetes in the U.S. population in 1988–1994 and 2005–2006. Diabetes Care. 2009;32(2):287–294
   PubMed Web of Science ®Google Scholar
• . Gilmer TP, O'Connor PJ. The growing importance of diabetes screening. Diabetes Care. 2010;33(7):1695–1697
   PubMed Web of Science ®Google Scholar
• . Gerstein HC, Miller ME, Byington RP, ; Action to Control Cardiovascular Risk in Diabetes Study Group. Effects of intensive glucose lowering in type 2 diabetes. N Engl J Med. 2008;358(24): 2545–2559
   PubMed Web of Science ®Google Scholar
• . World Health Organization/International Diabetes Federation. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva, Switzerland: WHO/IDF; 2006. http://www.who.int/diabetes/publications/Definition%20and%20diagnosis%20of%20diabetes_new.pdf. Accessed April 16, 2012
   Google Scholar
• . American Diabetes Association. Executive summary: standards of medical care in diabetes—2012. Diabetes Care. 2012;35( suppl 1): S4–S10
   PubMed Web of Science ®Google Scholar
• . World Health Organization. Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus. WHO/NMH/CHP/CPM/11.1; 2011. http://www.who.int/diabetes/publications/report-hba1c_2011.pdf. Accessed April 17, 2012
   Google Scholar
• . Handelsman Y, Mechanick JI, Blonde L, ; AACE Task Force for Developing Diabetes Comprehensive Care Plan. American Association of Clinical Endocrinologists Medical Guidelines for Clinical Practice for developing a diabetes mellitus comprehensive care plan. Endocr Pract. 2011;17( suppl 2):1–53
   PubMed Web of Science ®Google Scholar
• . Czupryniak L. Guidelines for the management of type 2 diabetes: is ADA and EASD consensus more clinically relevant than the IDF recommendations? Diabetes Res Clin Pract. 2009;86( suppl 1): S22–S25
   PubMedGoogle Scholar
• . Dixon JB, Zimmet P, Alberti KG, Rubino F; International Diabetes Federation Taskforce on Epidemiology and Prevention. Bariatric surgery: an IDF statement for obese type 2 diabetes. Surg Obes Relat Dis. 2011;7(4): 433–447
   PubMedGoogle Scholar
• . Holt RI, Young BS, Hitman GA, Alberti KG. The publication of Diabetes UK position statements and care recommendations. Diabet Med. 2011;28(5):507
   PubMedGoogle Scholar
• . American Diabetes Association. Standards of medical care in diabetes—2012. Diabetes Care. 2012;35( suppl 1):S11–S63
   PubMed Web of Science ®Google Scholar
• . Bergman M. Inadequacies of absolute threshold levels for diagnosing prediabetes. Diabetes Metab Res Rev. 2010;26(1):3–6
   PubMed Web of Science ®Google Scholar
• . Genuth S, Alberti KG, Bennett P, ; Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus. Diabetes Care. 2003;26(11):3160–3167
   PubMed Web of Science ®Google Scholar
• . American Diabetes Association. Standards of medical care in diabetes—2010. Diabetes Care. 2010;33( suppl 1):S11–S61
   PubMed Web of Science ®Google Scholar
• . Noda M, Kato M, Takahashi Y, . Fasting plasma glucose and 5-year incidence of diabetes in the JPHC diabetes study—suggestion for the threshold for impaired fasting glucose among Japanese. Endocr J. 2010;57(7):629–637
   PubMedGoogle Scholar
• . Heianza Y, Hara S, Arase Y, . HbA1c 5.7–6.4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. Lancet. 2011;378(9786):147–155
   PubMed Web of Science ®Google Scholar
• . Cosson E, Hamo—Tchatchouang E, Banu I, . A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and/or HbA1c are measured in overweight or obese patients. Diabetes Metab. 2010;36(4):312–318
   PubMedGoogle Scholar
• . International Expert Committee. International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes. Diabetes Care. 2009;32(7):1327–1334
   PubMed Web of Science ®Google Scholar
• . Cosson E, Nguyen MT, Hamo—Tchatchouang E, . What would be the outcome if the American Diabetes Association recommendations of 2010 had been followed in our practice in 1998–2006? Diabet Med. 2011;28(5):567–574
   PubMedGoogle Scholar
• . Silventoinen K, Pankow J, Lindström J, Jousilahti P, Hu G, Tuomilehto J. The validity of the Finnish Diabetes Risk Score for the prediction of the incidence of coronary heart disease and stroke, and total mortality. Eur J Cardiovasc Prev Rehabil. 2005;12(5):451–458
   PubMedGoogle Scholar
• . Costa B, Barrio F, Cabré JJ, ; DE-PLAN-CAT Research Group. Shifting from glucose diagnostic criteria to the new HbA1c criteria would have a profound impact on prevalence of diabetes among a high-risk Spanish population. Diabet Med. 2011;28(10): 1234–1237
   PubMedGoogle Scholar
• . Bersoux S, Cook CB, Wu Q, . Hemoglobin A1c testing alone does not sufficiently identify patients with prediabetes. Am J Clin Pathol. 2011;135(5):674–677
   PubMed Web of Science ®Google Scholar
• . Zhuo X, Zhang P, Selvin E, . Alternative HbA1c cutoffs to identify high-risk adults for diabetes prevention: a cost-effectiveness perspective. Am J Prev Med. 2012;42(4):374–381
   PubMed Web of Science ®Google Scholar
• . Malkani S, Mordes JP. Implications of using hemoglobin A1C for diagnosing diabetes mellitus. Am J Med. 2011;124(5): 395–401
   PubMed Web of Science ®Google Scholar
• . Ziemer DC, Kolm P, Weintraub WS, . Glucose-independent, black-white differences in hemoglobin A1c levels: a cross-sectional analysis of 2 studies. Ann Intern Med. 2010;152(12):770–777
   PubMed Web of Science ®Google Scholar
• . Ackermann RT, Cheng YJ, Williamson DF, Gregg EW. Identifying adults at high risk for diabetes and cardiovascular disease using hemoglobin A1c National Health and Nutrition Examination Survey 2005–2006. Am J Prev Med. 2011;40(1):11–17
   PubMed Web of Science ®Google Scholar
• . Valdés S, Botas P, Delgado E, Alvarez F, Díaz—Cadórniga F. HbA1c in the prediction of type 2 diabetes compared with fasting and 2-h post-challenge plasma glucose: The Asturias study (1998–2005). Diabetes Metab. 2011;37(1):27–32
   PubMed Web of Science ®Google Scholar
• . West B, Parikh P, Arniella G, Horowitz CR. Observations and recommendations for community-based diabetes screenings. Diabetes Educ. 2010;36(6):887–893
   PubMedGoogle Scholar
• . Gavi S, Hensley J. Diagnosis and management of type 2 diabetes in adults: a review of the ICSI guideline. Geriatrics. 2009;64(6):12–17, 29
   PubMedGoogle Scholar
• . Twigg SM, Kamp MC, Davis TM, Neylon EK, Flack JR; Australian Diabetes Society; Australian Diabetes Educators Association. Prediabetes: a position statement from the Australian Diabetes Society and Australian Diabetes Educators Association. Med J Aust. 2007;186(9): 461–465
   PubMed Web of Science ®Google Scholar
• . Lu YH, Lu JM, Wang SY, . Outcome of intensive integrated intervention in participants with impaired glucose regulation in China. Adv Ther. 2011;28(6):511–519
   PubMedGoogle Scholar
• . Moore SM, Hardie EA, Hackworth NJ, . Can the onset of type 2 diabetes be delayed by a group-based lifestyle intervention? A randomised control trial. Psychol Health. 2011;26(4): 485–499
   PubMed Web of Science ®Google Scholar
• . Saito T, Watanabe M, Nishida J, ; Zensharen Study for Prevention of Lifestyle Diseases Group. Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial. Arch Intern Med. 2011; 171(15):1352–1360
   PubMedGoogle Scholar
• . Parikh P, Simon EP, Fei K, Looker H, Goytia C, Horowitz CR. Results of a pilot diabetes prevention intervention in East Harlem, New York City: Project HEED. Am J Public Health. 2010;100( suppl 1): S232–S239
   PubMedGoogle Scholar
• . Wan Q, Wang F, Guan Q, . Regression to normoglycaemia by fenofibrate in pre-diabetic subjects complicated with hypertriglyceridaemia: a prospective randomized controlled trial. Diabet Med. 2010;27(11):1312–1317
   PubMedGoogle Scholar
• . Rosenstock J, Klaff LJ, Schwartz S, . Effects of exenatide and lifestyle modification on body weight and glucose tolerance in obese subjects with and without pre-diabetes. Diabetes Care. 2010;33(6):1173–1175
   PubMed Web of Science ®Google Scholar
• . Astrup A, Rössner S, Van Gaal L, ; NN8022-1807 Study Group. Effects of liraglutide in the treatment of obesity: a randomised, double-blind, placebo-controlled study. Lancet. 2009;374(9701):1606–1616
   PubMed Web of Science ®Google Scholar
• . Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE; Diabetes Prevention Program Research Group. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study. Lancet. 2012;379(9833):2243–2251
   PubMed Web of Science ®Google Scholar
• . Southwood RL. Have clinical studies demonstrated diabetes prevention or delay of diabetes through early treatment? Am J Ther. 2010;17(2):201–209
   PubMedGoogle Scholar
• . Geiss LS, James C, Gregg EW, Albright A, Williamson DF, Cowie CC. Diabetes risk reduction behaviors among U.S. adults with prediabetes. Am J Prev Med. 2010;38(4):403–409
   PubMedGoogle Scholar
• . International Diabetes Federation. Fact sheet: impaired glucose tolerance (IGT). http://www.idf.org/fact-sheets/impaired-glucose-tolerance. Accessed April 13, 2012
   Google Scholar
• . Diabetes UK Position Statement: consensus-based recommendations on the definition, identification and management of impaired glucose regulation (IGR) or prediabetes. London, UK: Diabetes UK; 2011
   Google Scholar
• . Health care guideline: diagnosis and management of type 2 diabetes mellitus in adults. Bloomington, MN: Institute for Clinical Systems Improvement; 14 ed; 2010
   Google Scholar